Hakan Özdoğu

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 366 citations

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +11

Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group

Meral Beksaç, Rauf Haznedar, Tülin Firatli‐Tuglular et al. · European Journal Of Haematology · 2010 · 143 citations

Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy

Süheyl Asma, İlknur Kozanoğlu, Ebru Tarım et al. · Transfusion · 2014 · 54 citations

RHINO-ORBITAL-CEREBRAL MUCORMYCOSIS WITH DIFFERENT CEREBRAL INVOLVEMENTS: INFARCT, HEMORRHAGE, AND OPHTHALMOPLEGIA

Zafer Koç, Filiz Koç, Deniz Yerdelen et al. · International Journal of Neuroscience · 2007 · 53 citations

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia

Arnon Nagler, Abraham S. Kanate, Myriam Labopin et al. · Haematologica · 2020 · 51 citations · Full text

Cell Therapy, Anti-thymocyte Globulin, Transplantation +15